Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

DAHLIA BIOSCIENCES, INC. — Funding, Investors & Profile — Capbase

← All companies

Compare History

DAHLIA BIOSCIENCES, INC.

Private

Won 2 federal SBIR/STTR research awards from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

SAM UEI: LMAJJM9962F5

Founded: —Source: [GOV]
Headquarters: ORINDA, CaliforniaSource: [GOV]
Headcount: 2Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

DAHLIA BIOSCIENCES, INC. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $599,106 in 2020. These are non-dilutive federal research grants, not equity financing. The company is based in ORINDA, California.

Funding rounds

2 rounds

STTR Phase I award (HHS)GrantApr 2020Source: [GOV]
$299.1K
—post-money
STTR Phase I award (HHS)

Investors

No investors recorded yet for DAHLIA BIOSCIENCES, INC..

Add an investor

People

Leadership

MITCHELL OCONNELLPrincipal investigatorSince 2021Source: [GOV]

Acquisitions

DAHLIA BIOSCIENCES, INC. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for DAHLIA BIOSCIENCES, INC..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Grant

Dec 2020Source: [GOV]

$300K

—post-money